Pacific Biosciences of California Inc. buy Cantor Fitzgerald
Start price
31.10.23
/
50%
€6.27
Target price
31.10.24
€10.36
Performance (%)
-68.90%
End price
01.11.24
€1.95
Summary
This prediction ended on 01.11.24 with a price of €1.95. The BUY prediction by Cantor_Fitzgerald for Pacific Biosciences of California Inc. performed very badly with a performance of -68.90%. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Pacific Biosciences of California Inc. | 24.793% | 24.793% | 39.816% |
| iShares Core DAX® | 3,59 % | 3,93 % | 15,38 % |
| iShares Nasdaq 100 | 5,81 % | 5,52 % | 41,46 % |
| iShares Nikkei 225® | 4,08 % | 8,46 % | 48,95 % |
| iShares S&P 500 | 4,14 % | 4,04 % | 31,59 % |
Comments by Cantor_Fitzgerald for this prediction
In the thread Pacific Biosciences of California Inc. diskutieren
Pacific Biosciences of California, Inc. (NASDAQ: PACB) was upgraded by analysts at Cantor Fitzgerald from a "neutral" rating to an "overweight" rating. They now have a $11.00 price target on the stock.
Ratings data for PACB provided by MarketBeat
In the thread Trading Pacific Biosciences of California Inc.
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Cantor_Fitzgerald for Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€1.41
08.08.24
08.08.24
€3.21
08.08.25
08.08.25
-19.66%
09.08.25
09.08.25
